Actively Recruiting

Phase 2
Age: 40Years - 75Years
All Genders
NCT07292714

A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Led by Mabwell (Shanghai) Bioscience Co., Ltd. · Updated on 2025-12-18

360

Participants Needed

51

Research Sites

133 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study is a Phase II, multicenter, double-blind, randomized, parallel, placebo-controlled clinical trial designed to evaluate the efficacy, safety of 9MW1911 in patients with Chronic Obstructive Pulmonary Disease (COPD).

CONDITIONS

Official Title

A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who Can Participate

Age: 40Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female patients aged 40 to 75 years inclusive
  • Physician diagnosis of COPD for at least 1 year at screening
  • History of 2 or more moderate or 1 or more severe COPD exacerbations within 12 months prior to screening
  • Moderate-to-severe COPD with post-bronchodilator FEV1/FVC ratio below 0.7 and post-bronchodilator FEV1% predicted between 20% and 80% at screening
  • Body Mass Index between 16 kg/m² and 32 kg/m²
  • Current or former smoker with a smoking history of at least 10 pack-years
  • Receiving standard care controller therapy for at least 3 months prior to screening and stable dose for at least 1 month prior to screening
Not Eligible

You will not qualify if you...

  • Current diagnosis or history of asthma
  • Diagnosis of Alpha-1 Antitrypsin Deficiency
  • Other significant lung diseases besides COPD, such as sarcoidosis, interstitial lung diseases, bronchiectasis, cystic fibrosis, constrictive bronchiolitis, severe pulmonary hypertension
  • Long-term oxygen treatment over 15 hours per day, mechanical ventilation, or significant apnea needing CPAP or non-invasive ventilation
  • History of lung removal or lung volume reduction surgery within 12 months prior to screening or planned surgery during the study
  • Participation in pulmonary rehabilitation or planned rehabilitation within 4 weeks of screening
  • Active respiratory infections during screening
  • Moderate to severe COPD exacerbations within 4 weeks prior to or during screening
  • Recent infections requiring hospitalization or antibiotics within 4 weeks prior to or during screening
  • Treatment with oral, intravenous, or intramuscular corticosteroids over 10 mg prednisone per day within 4 weeks prior to study medication
  • Recent heart attack, unstable angina within 12 months, or severe heart failure within 6 months prior to screening
  • History or risk factors for dangerous heart rhythms
  • Recent transient ischemic attack or stroke within 6 months prior to screening
  • Unstable cardiovascular conditions like pulmonary embolism or deep vein thrombosis within 6 months before screening
  • Active tuberculosis or certain infections unless inactive as judged by researchers
  • Positive tests for HIV, active hepatitis B or C infection, or syphilis
  • Active autoimmune disease or immunosuppressive therapy for autoimmune diseases
  • Active or recent malignancy except certain cured low-grade tumors
  • Recent live attenuated vaccine within 4 weeks prior to or during screening
  • Recent biologic therapy within 3 months prior to screening
  • Recent investigational therapy within 3 months or 5 drug half-lives prior to screening
  • Significant ECG abnormalities such as prolonged QTc
  • Liver enzyme or bilirubin levels above specified limits
  • Reduced kidney function (eGFR below 60 mL/min/1.73m2)
  • Serious medical conditions or lab abnormalities that could affect safety or participation
  • History of alcohol or substance abuse within 12 months prior to screening
  • Severe allergic reactions to biologic agents or components of the study drug
  • Pregnant or breastfeeding women, or positive pregnancy test at screening
  • Any condition the investigator believes makes participation inappropriate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 51 locations

1

Chizhou Central Hospital

Chizhou, Anhui, China

Actively Recruiting

2

Anhui Chest Hospital

Hefei, Anhui, China

Actively Recruiting

3

Gansu Provincial People's Hospital

Lanzhou, Gansu, China

Actively Recruiting

4

Huizhou Third People's Hospital

Huizhou, Guangdong, China

Actively Recruiting

5

Jiangmen Central Hospital

Jiangmen, Guangdong, China

Actively Recruiting

6

Qingyuan Hospital Affiliated to Guangzhou Medical University

Qingyuan, Guangdong, China

Actively Recruiting

7

The Affiliated Hospital of Zunyi Medical University

Zunyi, Guizhou, China

Actively Recruiting

8

Hebei PetroChina Central Hospital

Langfang, Hebei, China

Actively Recruiting

9

The First Affiliated Hospital of Nanyang Medical College

Nanyang, Henan, China

Actively Recruiting

10

The First Affiliated Hospital of Xinxiang Medical University

Xinxiang, Henan, China

Actively Recruiting

11

Xinxiang First People's Hospital

Xinxiang, Henan, China

Actively Recruiting

12

Henan Provincial People's Hospital

Zhengzhou, Henan, China

Actively Recruiting

13

Jingzhou First People's Hospital

Jinzhou, Hubei, China

Actively Recruiting

14

Yichang Central People's Hospital

Yichang, Hubei, China

Actively Recruiting

15

The Third Hospital of Changsha

Changsha, Hunan, China

Actively Recruiting

16

The First Affiliated Hospital of University of South China

Hengyang, Hunan, China

Actively Recruiting

17

Shaoyang Central Hospital

Shaoyang, Hunan, China

Actively Recruiting

18

Xiangyang Central Hospital

Xiangyang, Hunan, China

Actively Recruiting

19

Yongzhou Central Hospital

Yongzhou, Hunan, China

Actively Recruiting

20

Yueyang Central Hospital

Yueyang, Hunan, China

Actively Recruiting

21

The Affiliated Hospital of Xuzhou Medical University

Xuzhou, Jiangsu, China

Actively Recruiting

22

Affiliated Hospital of Yangzhou University

Yangzhou, Jiangsu, China

Actively Recruiting

23

Affiliated Hospital of Jiangsu University

Zhenjiang, Jiangsu, China

Actively Recruiting

24

Jiujiang First People's Hospital

Jiujiang, Jiangxi, China

Not Yet Recruiting

25

Jiangxi Provincial People's Hospital

Nanchang, Jiangxi, China

Actively Recruiting

26

Pingxiang People's Hospital

Pingxiang, Jiangxi, China

Actively Recruiting

27

Shengjing Hospital of China Medical University

Shenyang, Liaoning, China

Actively Recruiting

28

Inner Mongolia Baogang Hospital

Baotou, Neimenggu, China

Actively Recruiting

29

Heze Municipal Hospital

Heze, Shandong, China

Actively Recruiting

30

Shandong Provincial Hospital

Jinan, Shandong, China

Actively Recruiting

31

Shandong Provincial Public Health Clinical Center

Jinan, Shandong, China

Actively Recruiting

32

Weifang Second People's Hospital

Weifang, Shandong, China

Actively Recruiting

33

Jinmei Group General Hospital

Jincheng, Shanxi, China

Actively Recruiting

34

Shanxi Bethune Hospital

Taiyuan, Shanxi, China

Actively Recruiting

35

Xi'an Chest Hospital

Xi’an, Shanxi, China

Actively Recruiting

36

Chengdu Fifth People's Hospital

Chengdu, Sichuan, China

Actively Recruiting

37

Yibin Second People's Hospital

Yibin, Sichuan, China

Actively Recruiting

38

Yunnan Provincial First People's Hospital

Kunming, Yunnan, China

Actively Recruiting

39

Huzhou Central Hospital

Huzhou, Zhejiang, China

Actively Recruiting

40

Jiaxing First Hospital

Jiaxing, Zhejiang, China

Actively Recruiting

41

Taizhou Hospital of Zhejiang Province

Taizhou, Zhejiang, China

Actively Recruiting

42

Beijing Chaoyang Hospital

Beijing, China

Actively Recruiting

43

Beijing Luhe Hospital

Beijing, China

Actively Recruiting

44

Peking University Third Hospital

Beijing, China

Actively Recruiting

45

Chongqing jiangjin hospital

Chongqing, China

Actively Recruiting

46

The Second Affiliated Hospital of Chongqing Medical University

Chongqing, China

Actively Recruiting

47

Inner Mongolia Autonomous Region People's Hospital

Neimeng, China

Actively Recruiting

48

Chongming Hospital Affiliated to Shanghai University of Medicine & Health Sciences

Shanghai, China

Actively Recruiting

49

Shanghai Fifth People's Hospital

Shanghai, China

Actively Recruiting

50

Shanghai Pulmonary Hospital

Shanghai, China

Actively Recruiting

51

Yichang Central People's Hospital

Yichang, China

Actively Recruiting

Loading map...

Research Team

Y

Yongchang Sun, Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here